title: Presence of pituitary adenylate cyclase-activating polypeptide 38-immuno-like material in the brain and ovary of the female crested newt, Triturus carnifex: its involvement in the ovarian synthesis of prostaglandins and steroids.
abstract: The presence of pituitary adenylate cyclase-activating peptide (PACAP) 38-immuno-like material (PACAP 38-IL) in the brain and ovary of the crested newt, Triturus carnifex, and its action on ovarian steroidogenesis and prostaglandin synthesis were evaluated. The HPLC, brain and ovary extract peaks that eluted like PACAP 38 were considered PACAP 38-like material. The concentrations of PACAP 38-II in the HPLC extracts were measured by RIA. T. carnifex ovary was incubated with PACAP 38, brain and ovary PACAP 38-IL, and inhibitors of cyclooxygenase (COX), adenylate cyclase (AC) and phospholipase C (PLC) for 30 and 60 min. PACAI 38, and brain and ovary PACAP 38-IL increased prostaglandin E2 (PGE2) (30 and 60 min), and progesterone and corticosterone (60 min), but decreased oestradiol-17 beta (60 min). COX and PLC inhibitors counteracted the increases in PGE2, progesterone and corticosterone and the decrease in oestradiol-17 beta, and the AC, inhibitor also counteracted them except for PGE2. These results suggest that PACAP 38-IL, present in T. carnifex brain and ovary, acts on PLC, inducing the increase of PGE2 which, in turn, acting on AC, induces increases in progesterone and corticosterone and a decrease in oestradiol-17 beta.
authors.affiliation: Department of Molecular, Cellular and Animal Biology, University of Camerino, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Gobbetti
authors.forename: M
authors.initials: M
authors.lastname: Zerani
authors.forename: A
authors.initials: A
authors.lastname: Miano
authors.forename: M
authors.initials: M
authors.lastname: Bramucci
authors.forename: O
authors.initials: O
authors.lastname: Murri
authors.forename: D
authors.initials: D
authors.lastname: Amici
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology; D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry; D002851:Chromatography, High Pressure Liquid; D003345:Corticosterone / Q000096:biosynthesis; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015232:Dinoprostone / Q000096:biosynthesis; D005260:Female; D009479:Neuropeptides / Q000032:analysis / Q000378:metabolism*; D018377:Neurotransmitter Agents / Q000032:analysis / Q000378:metabolism*; D009924:Organ Culture Techniques; D010053:Ovary / Q000737:chemistry / Q000378:metabolism*; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; D011374:Progesterone / Q000096:biosynthesis; D011863:Radioimmunoassay; D012455:Salamandridae / Q000378:metabolism*; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology
chemical_list: D000067956:Adenylyl Cyclase Inhibitors; D016861:Cyclooxygenase Inhibitors; D009479:Neuropeptides; D018377:Neurotransmitter Agents; D051219:Pituitary Adenylate Cyclase-Activating Polypeptide; C002230:1-methyladenosine; D003189:p-Methoxy-N-methylphenethylamine; D011374:Progesterone; D010738:Type C Phospholipases; D000241:Adenosine; D015232:Dinoprostone; D001241:Aspirin; D003345:Corticosterone